BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2022
View Archived Issues
Study shows disease-linked DNA variants are active at different stages of T-cell activation
Read More
Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model
Read More
NLRP3 inflammasome inhibitor INF-176 for the treatment of Alzheimer's disease
Read More
MAb-loaded extracellular vesicles show potential as cancer therapeutics
Read More
Shanghai Yao Biotech discloses new TRK inhibitors
Read More
Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors
Read More
Tyligand Bioscience divulges GTPase KRAS mutant inhibitors
Read More
Betta Pharmaceuticals identifies new IDH inhibitors
Read More
Broadenbio synthesizes new MAP4K1 inhibitors
Read More
Morc2 S87L mutation in mice mimics human Charcot-Marie-Tooth disease
Read More
TrxR inhibitor Au-24 shows promise in vivo and in vitro for treating hepatocellular carcinoma
Read More
Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF
Read More
